Immune-related adverse events predict the therapeutic efficacy of pembrolizumab in urothelial cancer patients
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference5 articles.
1. Immune-related adverse events predict the therapeutic efficacy of anti-PD-1 antibodies in cancer patients;Rogado;Eur J Canc,2019
2. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1);Eisenhauer;Eur J Canc,2009
3. Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience;Fujii;Investig New Drugs,2018
4. Nivolumab in resected and unresectable metastatic melanoma: characteristics of immune-related adverse events and association with outcomes;Freeman-Keller;Clin Cancer Res,2016
5. Association of immunerelated adverse events with nivolumab efficacy in non-small-cell lung cancer;Haratani;JAMA Oncol,2018
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immune-Related Adverse Events of Genitourinary Cancer Patients, a Retrospective Cohort Study;Cancers;2024-08-31
2. Toxicity-Induced Discontinuation of Immune Checkpoint Inhibitors in Metastatic Urothelial Cancer: 6-Year Experience from a Specialized Uro-Oncology Center;Cancers;2024-06-18
3. Associations of concomitant medications with immune-related adverse events and survival in advanced cancers treated with immune checkpoint inhibitors: a comprehensive pan-cancer analysis;Journal for ImmunoTherapy of Cancer;2024-03
4. Latest evidence on clinical outcomes and prognostic factors of advanced urothelial carcinoma in the era of immune checkpoint inhibitors: a narrative review;Japanese Journal of Clinical Oncology;2023-12-18
5. Young patients show poor efficacy for immune checkpoint inhibitor combined therapy in metastatic gastrointestinal cancers;Frontiers in Oncology;2023-05-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3